BRIEF published on 03/25/2026 at 15:16, 7 months 20 days ago NANOBIOTIX denies takeover rumors Biotechnology Takeover NANOBIOTIX Rumors Nanoparticles
BRIEF published on 03/25/2026 at 15:16, 7 months 20 days ago NANOBIOTIX Responds to Media Speculation on Takeover Intentions Biotechnology Nanotechnology Takeover Speculation NANOBIOTIX Public Statement
BRIEF published on 03/25/2026 at 15:16, 7 months 20 days ago NANOBIOTIX répond aux spéculations médiatiques concernant d'éventuelles intentions de rachat Biotechnologie Nanotechnologie Spéculations De Rachat NANOBIOTIX Déclaration Publique
BRIEF published on 03/25/2026 at 15:16, 7 months 20 days ago NANOBIOTIX dément les rumeurs de prise de contrôle Biotechnologie NANOBIOTIX Rumeurs Nanoparticules Prise De Contrôle
PRESS RELEASE published on 03/25/2026 at 15:11, 7 months 20 days ago NANOBIOTIX Statement Regarding Recent Media Speculation Nanobiotix issues statement addressing media speculation on public take-over intentions, denying any such plans and highlighting factual inaccuracies in recent reports Media Speculation Statement NANOBIOTIX Public Take-over Factual Inaccuracies
PRESS RELEASE published on 03/25/2026 at 15:11, 7 months 20 days ago Declaration de NANOBIOTIX concernant une recente rumeur mediatique Nanobiotix publie une déclaration officielle concernant une rumeur de prise de contrôle. Aucun processus en cours. La société réaffirme son engagement envers l'innovation dans le domaine de la biotechnologie Innovation Déclaration Biotechnologie NANOBIOTIX Rumeur
BRIEF published on 03/12/2026 at 21:20, 8 months 2 days ago Nanobiotix Announces Voting Rights and Share Capital Details Euronext Paris Share Capital Voting Rights Nasdaq NANOBIOTIX
BRIEF published on 03/12/2026 at 21:20, 8 months 2 days ago Nanobiotix annonce les détails relatifs aux droits de vote et au capital social Euronext Paris Capital Social Nasdaq Droit De Vote NANOBIOTIX
PRESS RELEASE published on 03/12/2026 at 21:15, 8 months 2 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital details as of February 28, 2026, on Euronext Paris and Nasdaq markets. Learn about their disruptive therapeutic approaches and global presence Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/25/2026 at 22:20, 8 months 17 days ago NANOBIOTIX Présente à des Conférences Clés en Mars Biotechnologie Conférences Investisseurs NANOBIOTIX Avancées Cliniques Traitements Cancer
Published on 11/14/2026 at 12:56, 11 hours 44 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 23 hours 10 minutes ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 1 hour ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 2 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 5 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 5 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 1 day 13 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 13 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 1 day 16 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 1 hour ago Belgrano continues the implementation of its public share buyback offer (OPRA)
